Transactions
Mar. 20, 2001
Latham & Watkins: AVIRON FINANCING IS FIRST OF ITS KIND IN BIOTECH INDUSTRY
Biotechnology company Aviron has completed a $400 financing deal, consisting of both debt and equity. It is the first such financing combination in the biotech industry.
Biotechnology company Aviron has completed a $400 financing deal, consisting of both debt and equity. It is the first such financing combination in the biotech industry.
The financing consists of common stock and 51/4 percent convertible subordinated notes due 2008.
Mountain View's Aviron develops vaccines from weakened but liv...
The financing consists of common stock and 51/4 percent convertible subordinated notes due 2008.
Mountain View's Aviron develops vaccines from weakened but liv...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In